Double-Blind Parallel-Group Randomized Study Of Efficacy And Safety Of 'Continuous Use' Of Celecoxib Vs. The 'Usual Use' Of Celecoxib In The Treatment Of Subjects With Chronic Osteoarthritis Of The Hip Or Knee Who Require an Anti-Inflammatory Medication for Control Of Their Pain.

Trial Profile

Double-Blind Parallel-Group Randomized Study Of Efficacy And Safety Of 'Continuous Use' Of Celecoxib Vs. The 'Usual Use' Of Celecoxib In The Treatment Of Subjects With Chronic Osteoarthritis Of The Hip Or Knee Who Require an Anti-Inflammatory Medication for Control Of Their Pain.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2012

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 09 Jun 2012 WOMAC outcomes presented at the 13th Annual Congress of the European League Against Rheumatism.
    • 09 Jun 2012 Disease flare outcomes presented at the 13th Annual Congress of the European League Against Rheumatism.
    • 01 Nov 2011 Results published in The Journal of rheumatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top